STAAR Surgical Co. Form 8-K Summary
Business Context and Reporting Period
STAAR Surgical Co. (NASDAQ: STAA) filed this Current Report on August 12, 2026. The filing announces the publication of financial results for the quarter ended July 3, 2026, via a press release furnished as Exhibit 99.1. The Company is incorporated in Delaware and maintains its principal executive offices in Lake Forest, California.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release (Exhibit 99.1) referenced in Item 2.02 but are not detailed in the body of this Form 8-K.
Material Changes
No material changes versus the prior comparable period are described in the text of this filing. The document serves solely as a notification of the results release and the scheduled conference call.
Guidance, Outlook, and Management Commentary
Management, including the President and CEO and the Executive Vice President and CFO, scheduled a conference call and webcast for August 12, 2026, at 5:30 p.m. Eastern / 2:30 p.m. Pacific to discuss the results for the quarter ended August 12, 2026. The filing explicitly states that the information in Items 2.02 and 7.01, including the press release, is not deemed "filed" under Section 18 of the Exchange Act and shall not be incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, earnings, and cash flow figures for the quarter ended July 3, 2026.
- Verify the discrepancy in the reporting period mentioned in Item 7.01 (quarter ended August 12, 2026) versus Item 2.02 (quarter ended July 3, 2026) during the conference call.
- Confirm the Company's liquidity position and debt levels as detailed in the full press release.
- Check for any forward-looking guidance or updated outlook provided during the August 12, 2026, conference call.